Public call: Update of the WHO high-priority target product profiles for TB diagnostics

The World Health Organization (WHO) is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation drug-susceptibility testing at peripheral centers.

The deadline for submitting comments is 31 January 2021.

For further details about the call, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By World Health Organization

Published: Jan. 6, 2021, 11:17 p.m.

Last updated: Jan. 10, 2021, 11:17 p.m.

Tags: Diagnostics

Print Share